Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIELLE T LAND

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1730411786
CMS profile
10515393
Location
PHILADELPHIA, PA

General Payments · PY2021–2024

$44,958.16

  • Reported across 69 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,797.16

9 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $2,372.16 7
Incyte Corporation $1,050.00 1
Janssen Biotech, Inc. $375.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $22,190.36 31
PY2022 $10,315.00 15
PY2023 $8,655.64 14
PY2024 $3,797.16 9

Payment records · PY2024 (9)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $100.00 02/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105651490 CMS
AstraZeneca Pharmaceuticals LP $300.00 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105712436 CMS
AstraZeneca Pharmaceuticals LP $600.00 05/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104540006 CMS
AstraZeneca Pharmaceuticals LP $100.00 06/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105679671 CMS
AstraZeneca Pharmaceuticals LP $106.75 07/10/2024 Food and Beverage Undisputed 01/23/2026 1104277821 CMS
AstraZeneca Pharmaceuticals LP $15.41 07/10/2024 Travel and Lodging Undisputed 01/23/2026 1105456724 CMS
AstraZeneca Pharmaceuticals LP $1,150.00 07/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104214313 CMS
Incyte Corporation $1,050.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1141320089 CMS
Janssen Biotech, Inc. $375.00 01/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078584272 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.